Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > A tad more than 60
View:
Post by HighteawithIntrepid on Jun 30, 2015 10:51am

A tad more than 60

There is a few days tacked onto the 60 to write the
reply letter so don't panic for another 12 days.
so be cool until August 10 th.
Comment by 13PunterDog on Jun 30, 2015 11:12am
I think you meant Sept 10 Tea. Just saying. That's when the fun starts with everyone back from holidays. JMHO 13PD
Comment by HighteawithIntrepid on Jun 30, 2015 11:42am
Sorry 1 day in June as they filed on 29th 31 days in July  31 days in August  11 days in September as it is 14 days in press release for responding their reply so that is September 11.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities